Not sure how they have come up with the patient only being on MPL for 9 months.
Cohort 1
Announcement 6 January all 6 patients had been on the for 29 days of dosing
Cohort 2
Announcement 20 February 2023 first patient dosed
Announcement 28 April 2023 MND Trial successfully completes cohort 2
So when did the patient actually pass away if they had only for 9.5 months if they came from cohort 2 and with all patients in this cohort fully doesnt by 6 January 2023 that would mean they must have passed away by end of October 2023.
Or are my maths out or have PAA got it wrong
Ann: Appendix 4C & Quarterly Update, page-47
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $87.97K | 426.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10300 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 261000 | 3 |
View Market Depth
| Last trade - 15.59pm 26/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |